Akers Biosciences Inc  

(Public, LON:AKR)   Watch this stock  
Find more results for John Rauch
0.00 (0.00%)
Feb 2 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range     -
52 week 78.75 - 330.00
Open 95.00
Vol / Avg. 0.00/2,200.00
Mkt cap 6.51M*
P/E     -
Div/yield     -
EPS -1.30*
Shares 5.43M
Beta     -
Inst. own 17%
Nov 13, 2015
Q3 2015 Akers Biosciences Inc Earnings Call - Webcast
Nov 13, 2015
Q3 2015 Akers Biosciences Inc Earnings Release

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -1373.04% -70.64%
Operating margin -1383.97% -72.37%
EBITD margin - -64.48%
Return on average assets -76.69% -27.52%
Return on average equity -85.17% -33.21%
Employees 31 -
CDP Score - -


201 Grove Rd
WEST DEPTFORD, NJ 08086-2231
United States - Map
+1-856-8488698 (Phone)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


Akers Biosciences, Inc. develops, manufactures, and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory diseases and infectious diseases detection, as well as for on and off-the-job alcohol safety initiatives. The Company's primary focus is the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The Company's main products are a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.

Officers and directors

Raymond Francis Akers JR Executive Chairman of the Board, Secretary
Age: 56
John J. Gormally Chief Executive Officer
John C. Cheneval Executive Vice President, Sales and Marketing
Gary M. Rauch Senior Vice President - Finance, Treasurer
Age: 59
Christopher Ellis Vice President - Global Marketing
Robert E. Andrews Non-Executive Director
Age: 53
Raza Bokhari Non-Executive Director
Age: 48
Brandon Thomas Knox Independent Director
Age: 35
Thomas James Knox Independent Director
Age: 73
Gavin Edwin David Moran Independent Director
Age: 43